Copyright Reports & Markets. All rights reserved.

Global Blood Stream Infection Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Blood Stream Infection Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Blood Stream Infection Testing by Type
    • 1.3.1 Overview: Global Blood Stream Infection Testing Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Blood Stream Infection Testing Consumption Value Market Share by Type in 2023
    • 1.3.3 Conventional Blood Culture Tests
    • 1.3.4 PCR Methods
    • 1.3.5 Nucleic Acid Testing
    • 1.3.6 Mass Spectroscopy
    • 1.3.7 Point of Care Testing
  • 1.4 Global Blood Stream Infection Testing Market by Application
    • 1.4.1 Overview: Global Blood Stream Infection Testing Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Independent Diagnostic Centers
    • 1.4.4 Others
  • 1.5 Global Blood Stream Infection Testing Market Size & Forecast
  • 1.6 Global Blood Stream Infection Testing Market Size and Forecast by Region
    • 1.6.1 Global Blood Stream Infection Testing Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Blood Stream Infection Testing Market Size by Region, (2019-2030)
    • 1.6.3 North America Blood Stream Infection Testing Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Blood Stream Infection Testing Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Blood Stream Infection Testing Market Size and Prospect (2019-2030)
    • 1.6.6 South America Blood Stream Infection Testing Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Blood Stream Infection Testing Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 BD
    • 2.1.1 BD Details
    • 2.1.2 BD Major Business
    • 2.1.3 BD Blood Stream Infection Testing Product and Solutions
    • 2.1.4 BD Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 BD Recent Developments and Future Plans
  • 2.2 bioMérieux
    • 2.2.1 bioMérieux Details
    • 2.2.2 bioMérieux Major Business
    • 2.2.3 bioMérieux Blood Stream Infection Testing Product and Solutions
    • 2.2.4 bioMérieux Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 bioMérieux Recent Developments and Future Plans
  • 2.3 Cepheid
    • 2.3.1 Cepheid Details
    • 2.3.2 Cepheid Major Business
    • 2.3.3 Cepheid Blood Stream Infection Testing Product and Solutions
    • 2.3.4 Cepheid Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Cepheid Recent Developments and Future Plans
  • 2.4 Roche Diagnostics
    • 2.4.1 Roche Diagnostics Details
    • 2.4.2 Roche Diagnostics Major Business
    • 2.4.3 Roche Diagnostics Blood Stream Infection Testing Product and Solutions
    • 2.4.4 Roche Diagnostics Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Roche Diagnostics Recent Developments and Future Plans
  • 2.5 IRIDICA
    • 2.5.1 IRIDICA Details
    • 2.5.2 IRIDICA Major Business
    • 2.5.3 IRIDICA Blood Stream Infection Testing Product and Solutions
    • 2.5.4 IRIDICA Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 IRIDICA Recent Developments and Future Plans
  • 2.6 Bruker
    • 2.6.1 Bruker Details
    • 2.6.2 Bruker Major Business
    • 2.6.3 Bruker Blood Stream Infection Testing Product and Solutions
    • 2.6.4 Bruker Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Bruker Recent Developments and Future Plans
  • 2.7 Nanosphere
    • 2.7.1 Nanosphere Details
    • 2.7.2 Nanosphere Major Business
    • 2.7.3 Nanosphere Blood Stream Infection Testing Product and Solutions
    • 2.7.4 Nanosphere Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Nanosphere Recent Developments and Future Plans
  • 2.8 Siemens
    • 2.8.1 Siemens Details
    • 2.8.2 Siemens Major Business
    • 2.8.3 Siemens Blood Stream Infection Testing Product and Solutions
    • 2.8.4 Siemens Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Siemens Recent Developments and Future Plans
  • 2.9 AdvanDX
    • 2.9.1 AdvanDX Details
    • 2.9.2 AdvanDX Major Business
    • 2.9.3 AdvanDX Blood Stream Infection Testing Product and Solutions
    • 2.9.4 AdvanDX Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 AdvanDX Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Blood Stream Infection Testing Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Blood Stream Infection Testing by Company Revenue
    • 3.2.2 Top 3 Blood Stream Infection Testing Players Market Share in 2023
    • 3.2.3 Top 6 Blood Stream Infection Testing Players Market Share in 2023
  • 3.3 Blood Stream Infection Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Blood Stream Infection Testing Market: Region Footprint
    • 3.3.2 Blood Stream Infection Testing Market: Company Product Type Footprint
    • 3.3.3 Blood Stream Infection Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Blood Stream Infection Testing Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Blood Stream Infection Testing Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Blood Stream Infection Testing Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Blood Stream Infection Testing Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Blood Stream Infection Testing Consumption Value by Type (2019-2030)
  • 6.2 North America Blood Stream Infection Testing Consumption Value by Application (2019-2030)
  • 6.3 North America Blood Stream Infection Testing Market Size by Country
    • 6.3.1 North America Blood Stream Infection Testing Consumption Value by Country (2019-2030)
    • 6.3.2 United States Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Blood Stream Infection Testing Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Blood Stream Infection Testing Consumption Value by Type (2019-2030)
  • 7.2 Europe Blood Stream Infection Testing Consumption Value by Application (2019-2030)
  • 7.3 Europe Blood Stream Infection Testing Market Size by Country
    • 7.3.1 Europe Blood Stream Infection Testing Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 7.3.3 France Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Blood Stream Infection Testing Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Blood Stream Infection Testing Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Blood Stream Infection Testing Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Blood Stream Infection Testing Market Size by Region
    • 8.3.1 Asia-Pacific Blood Stream Infection Testing Consumption Value by Region (2019-2030)
    • 8.3.2 China Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 8.3.5 India Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Blood Stream Infection Testing Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Blood Stream Infection Testing Consumption Value by Type (2019-2030)
  • 9.2 South America Blood Stream Infection Testing Consumption Value by Application (2019-2030)
  • 9.3 South America Blood Stream Infection Testing Market Size by Country
    • 9.3.1 South America Blood Stream Infection Testing Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Blood Stream Infection Testing Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Blood Stream Infection Testing Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Blood Stream Infection Testing Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Blood Stream Infection Testing Market Size by Country
    • 10.3.1 Middle East & Africa Blood Stream Infection Testing Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Blood Stream Infection Testing Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Blood Stream Infection Testing Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Blood Stream Infection Testing Market Drivers
  • 11.2 Blood Stream Infection Testing Market Restraints
  • 11.3 Blood Stream Infection Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Blood Stream Infection Testing Industry Chain
  • 12.2 Blood Stream Infection Testing Upstream Analysis
  • 12.3 Blood Stream Infection Testing Midstream Analysis
  • 12.4 Blood Stream Infection Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Blood Stream Infection Testing market size was valued at USD 3785.7 million in 2023 and is forecast to a readjusted size of USD 5887.3 million by 2030 with a CAGR of 6.5% during review period.
    BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
    According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
    The Global Info Research report includes an overview of the development of the Blood Stream Infection Testing industry chain, the market status of Hospitals (Conventional Blood Culture Tests, PCR Methods), Independent Diagnostic Centers (Conventional Blood Culture Tests, PCR Methods), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Blood Stream Infection Testing.
    Regionally, the report analyzes the Blood Stream Infection Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Blood Stream Infection Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Blood Stream Infection Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Blood Stream Infection Testing industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Conventional Blood Culture Tests, PCR Methods).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Blood Stream Infection Testing market.
    Regional Analysis: The report involves examining the Blood Stream Infection Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Blood Stream Infection Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Blood Stream Infection Testing:
    Company Analysis: Report covers individual Blood Stream Infection Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Blood Stream Infection Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Independent Diagnostic Centers).
    Technology Analysis: Report covers specific technologies relevant to Blood Stream Infection Testing. It assesses the current state, advancements, and potential future developments in Blood Stream Infection Testing areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Blood Stream Infection Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Blood Stream Infection Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Conventional Blood Culture Tests
    PCR Methods
    Nucleic Acid Testing
    Mass Spectroscopy
    Point of Care Testing
    Market segment by Application
    Hospitals
    Independent Diagnostic Centers
    Others
    Market segment by players, this report covers
    BD
    bioMérieux
    Cepheid
    Roche Diagnostics
    IRIDICA
    Bruker
    Nanosphere
    Siemens
    AdvanDX
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Blood Stream Infection Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Blood Stream Infection Testing, with revenue, gross margin and global market share of Blood Stream Infection Testing from 2019 to 2024.
    Chapter 3, the Blood Stream Infection Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Blood Stream Infection Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Stream Infection Testing.
    Chapter 13, to describe Blood Stream Infection Testing research findings and conclusion.

    Buy now